Work

Biological heterogeneity in localized high-risk prostate cancer (LHRPC) from a study of neoadjuvant abiraterone acetate plus leuprolide acetate (LHRHa) versus LHRHa.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.5005

Authors: Eleni Efstathiou, Weimin Li, Michael Gormley, Ryan McMullin, Deborah Sokol Ricci, John W. Davis, Elsa M. Li Ning Tapia, Patricia Troncoso, Mark Anton Titus, Anh Hoang, Sijin Wen, Amado J. Zurita, Namphuong Tran, Weimin Peng, Thian Kheoh, Arturo Molina, Christopher Logothetis

Institutions: The University of Texas MD Anderson Cancer Center, Janssen Research & Development (United States), West Virginia University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590085844

Cites:

Cited by: 8

Related to: 10